Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness
NCT06138613
·
clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
705
Enrollment
INDUSTRY
Sponsor class
Conditions
Motion Sickness
Interventions
DRUG:
Tradipitant
Sponsor
Vanda Pharmaceuticals